483
Moore Clinical Research Inc.Moore Clinical Research Inc. – FDA 483, Mar 5, 2015
Record Details
During an inspection of Moore Clinical Research Inc. in Brandon, FL, the FDA observed a significant protocol deviation at this biopharmaceuticals clinical facility. An investigation was not conducted in accordance with the investigational plan, specifically regarding subject enrollment criteria. A subject was consented and randomized into a study despite being underage according to the protocol's inclusion criteria.
View Company Profile
ID · 4c537e9f-1742-47e5-8e96-c4c2e2f0f5ff
Other documents for Moore Clinical Research Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.